AAAAAA
Results: 1-25/42
Authors:
De Clercq, E
Andrei, G
Snoeck, R
De Bolle, L
Naesens, L
Degreve, B
Balzarini, J
Zhang, Y
Schols, D
Leyssen, P
Ying, C
Neyts, J
Citation: E. De Clercq et al., Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents, NUCLEOS NUC, 20(4-7), 2001, pp. 271-285
Authors:
Nakagaki, K
Nakagaki, K
Takahashi, K
Schols, D
De Clercq, E
Tabira, T
Citation: K. Nakagaki et al., CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes, J NEUROVIRO, 7(5), 2001, pp. 487-492
Authors:
Bezzi, P
Domercq, M
Brambilla, L
Galli, R
Schols, D
De Clercq, E
Vescovi, A
Bagetta, G
Kollias, G
Meldolesi, J
Volterra, A
Citation: P. Bezzi et al., CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity, NAT NEUROSC, 4(7), 2001, pp. 702-710
Authors:
De Clercq, E
Naesens, L
De Bolle, L
Schols, D
Zhang, Y
Neyts, J
Citation: E. De Clercq et al., Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8, REV MED VIR, 11(6), 2001, pp. 381-395
Authors:
Andrei, G
Snoeck, R
Schols, D
De Clercq, E
Citation: G. Andrei et al., Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positivecells, ONCOL RES, 12(9-10), 2001, pp. 397-408
Authors:
Boelaert, JR
Yaro, S
Augustijns, P
Meda, N
Schneider, YJ
Schols, D
Mols, R
De Laere, EA
Van de Perre, P
Citation: Jr. Boelaert et al., Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1, AIDS, 15(16), 2001, pp. 2205-2207
Authors:
Malkevitch, N
McDermott, DH
Yi, YJ
Grivel, JC
Schols, D
De Clercq, E
Murphy, PM
Glushakova, S
Collman, RG
Margolis, L
Citation: N. Malkevitch et al., Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5 Delta 32) and normal human lymphoid tissue, VIROLOGY, 281(2), 2001, pp. 239-247
Authors:
Hatse, S
Princen, K
Gerlach, LO
Bridger, G
Henson, G
De Clercq, E
Schwartz, TW
Schols, D
Citation: S. Hatse et al., Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100, MOLEC PHARM, 60(1), 2001, pp. 164-173
Authors:
Pluymers, W
Neamati, N
Pannecouque, C
Fikkert, V
Marchand, C
Burke, TR
Pommier, Y
Schols, D
De Clercq, E
Debyser, Z
Witvrouw, M
Citation: W. Pluymers et al., Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters (vol 58, pg 641, 2000), MOLEC PHARM, 59(2), 2001, pp. 403-403
Authors:
Aquaro, S
Menten, P
Struyf, S
Proost, P
Van Damme, J
De Clercq, E
Schols, D
Citation: S. Aquaro et al., The LD78 beta isoform of MIP-1 alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages, J VIROLOGY, 75(9), 2001, pp. 4402-4406
Authors:
Gorry, PR
Bristol, G
Zack, JA
Ritola, K
Swanstrom, R
Birch, CJ
Bell, JE
Bannert, N
Crawford, K
Wang, H
Schols, D
De Clercq, E
Kunstman, K
Wolinsky, SM
Gabuzda, D
Citation: Pr. Gorry et al., Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity, J VIROLOGY, 75(21), 2001, pp. 10073-10089
Authors:
Zhang, Y
de Bolle, L
Aquaro, S
van Lommel, A
De Clercq, E
Schols, D
Citation: Y. Zhang et al., Productive infection of primary macrophages with human herpesvirus 7, J VIROLOGY, 75(21), 2001, pp. 10511-10514
Authors:
Koning, FA
Schols, D
Schuitemaker, H
Citation: Fa. Koning et al., No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1, J VIROLOGY, 75(18), 2001, pp. 8848-8853
Authors:
Matthys, P
Hatse, S
Vermeire, K
Wuyts, A
Bridger, G
Henson, GW
De Clercq, E
Billiau, A
Schols, D
Citation: P. Matthys et al., AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice, J IMMUNOL, 167(8), 2001, pp. 4686-4692
Authors:
Struyf, S
Menten, P
Lenaerts, JP
Put, W
D'Haese, A
De Clercq, E
Schols, D
Proost, P
Van Damme, J
Citation: S. Struyf et al., Diverging binding capacities of natural LD78 beta isoforms of macrophage inflammatory protein-1 alpha to the CC chemokine receptors 1, 3 and 5 affecttheir anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils, EUR J IMMUN, 31(7), 2001, pp. 2170-2178
Authors:
Selten, JP
Veen, N
Feller, W
Blom, JD
Schols, D
Camoenie, W
Oolders, J
Van der Velden, M
Hoek, HW
Rivero, VMV
Van der Graaf, Y
Kahn, R
Citation: Jp. Selten et al., Incidence of psychotic disorders in immigrant groups to The Netherlands, BR J PSYCHI, 178, 2001, pp. 367-372
Authors:
Del Corno, M
Liu, QH
Schols, D
Clercq, EC
Gessani, S
Freedman, BD
Collman, RG
Citation: M. Del Corno et al., HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated proteinkinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling, BLOOD, 98(10), 2001, pp. 2909-2916
Authors:
Schols, D
De Clercq, E
Citation: D. Schols et E. De Clercq, Cellular receptors as targets for anti-human immunodeficiency virus agents, ANTIRETROVIRAL THERAPY, 2001, pp. 11-30
Authors:
Liu, QH
Williams, DA
McManus, C
Baribaud, F
Doms, RW
Schols, D
De Clercq, E
Kotlikoff, MI
Collman, RG
Freedman, BD
Citation: Qh. Liu et al., HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation, P NAS US, 97(9), 2000, pp. 4832-4837
Authors:
Witvrouw, M
Fikkert, V
Pluymers, W
Matthews, B
Mardel, K
Schols, D
Raff, J
Debyser, Z
De Clercq, E
Holan, G
Pannecouque, C
Citation: M. Witvrouw et al., Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (Reverse transcriptase/integrase) in the virus replicative cycle, MOLEC PHARM, 58(5), 2000, pp. 1100-1108
Authors:
Pluymers, W
Neamati, N
Pannecouque, C
Fikkert, V
Marchand, C
Burke, TR
Pommier, Y
Schols, D
De Clercq, E
Debyser, Z
Witvrouw, M
Citation: W. Pluymers et al., Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters, MOLEC PHARM, 58(3), 2000, pp. 641-648
Authors:
Daelemans, D
Schols, D
Witvrouw, M
Pannecouque, C
Hatse, S
van Dooren, S
Hamy, F
Klimkait, T
De Clercq, E
Vandamme, AM
Citation: D. Daelemans et al., A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: Inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry, MOLEC PHARM, 57(1), 2000, pp. 116-124
Authors:
Zhang, Y
Hatse, S
De Clercq, E
Schols, D
Citation: Y. Zhang et al., CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entryinto CD4(+) T cells, J VIROLOGY, 74(4), 2000, pp. 2011-2016
Authors:
Schramm, B
Penn, ML
Speck, RF
Chan, SY
De Clercq, E
Schols, D
Connor, RI
Goldsmith, MA
Citation: B. Schramm et al., Viral entry through CXCR4 is a pathogenic factor and therapeutic target inhuman immunodeficiency virus type 1 disease, J VIROLOGY, 74(1), 2000, pp. 184-192
Authors:
Witvrouw, M
Weigold, H
Pannecouque, C
Schols, D
De Clercq, E
Holan, G
Citation: M. Witvrouw et al., Potent Anti-HTV (type 1 and type 2) activity of polyoxometalates: Structure-activity relationship and mechanism of action, J MED CHEM, 43(5), 2000, pp. 778-783